Akari Therapeutics PLC (NASDAQ:AKTX)
| 4.05 BATS BZX Real-Time Price As of Sep 28 |  0.00 / 0.00%Today’s Change | 2.81 Today|||52-Week Range 13.40 | -56.91% Year-to-Date |
Latest AKTX News | Press Releases
No recent news for Akari Therapeutics PLC.
Today’s Trading
| Previous close | 4.05 |
| Today’s open | 4.05 |
| Day’s range | 4.05 - 4.05 |
| Volume | 300 |
| Average volume (3 months) | 28,202 |
| Market cap | $18.3M |
Data as of 3:40pm ET, 09/28/2023
Growth & Valuation
| Earnings growth (last year) | +30.08% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 7.53 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CBIOCatalyst Biosciences... | 0.00 | 0.00% |
| APTOAptose Biosciences I... | +0.10 | +3.60% |
| VBIVVBI Vaccines Inc | -0.02 | -2.19% |
| AQBAquaBounty Technolog... | +0.01 | +5.56% |
Data as of 9:48am ET, 09/29/2023
Financials
| Last reporting date | November 17, 2022 |
| EPS forecast (this quarter) | -$0.04 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$17.7M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters London, Greater London |
Forecasts
